NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure |
|
|
| Recruiting | 3 | 522 | RoW | D-1553 Tablet, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 10/26 | 12/27 | | |
| Not yet recruiting | 3 | 358 | RoW | TQB2450+Anlotinib, TQB2450 placebo + Anlotinib placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Small Cell Lung Cancer Limited Stage | 09/26 | 09/26 | | |
NCT04996329: Early Health Warning Intervention in Tobacco Control |
|
|
| Recruiting | N/A | 1000 | RoW | early health warning intervention | Peking University First Hospital, The Second Hospital of Hebei Medical University, Henan Provincial People's Hospital, Second Hospital of Jilin University, First Affiliated Hospital Xi'an Jiaotong University, Shandong Provincial Hospital, Shanxi Bethune Hospital, Tianjin Medical University General Hospital, The Affiliated Hospital of Inner Mongolia Medical University, The First Hospital of Qinhuangdao | Smoking Cessation | 12/22 | 12/22 | | |
